D detection of chromosomal abnormalities in human tumors have occurred with the development of new techniques. These have included new techniques to identify chromosomes such as chromosomal banding techniques, improved methods to culture cells, the use of growth factors, and more sensitive techniques to detect chromosomally abnormal cells. Cytogenetic analysis of human tumors is often technically difficult due to the presence of multiple abnormal cell lines and the complexity of the chromosomal pattern. Moreover, the interpretation of chromosomal banding patterns requires highly skilled personnel. These factors have led investigators to seek alternative methods for identifying chromosomal abnormalities. DNA-based or RNA-based techniques, such as Southern blot analysis of DNA or polymerase chain reaction (PCR) analysis of RNA from tumor cells, are being used increasingly to detect those abnormalities for which the involved genes have been identified. Recently, another technique has been developed that has applications in the detection of chromosomal abnormalities as well as other genetic changes in both interphase and metaphase cells, namely, tluorescence in situ hybridization (FISH).I4 Analysis of the cytogenetic pattern of nondividing cells by FISH was first introduced by Cremer et a14 and is often referred to as "interphase cytogenetic^."^ In the short time since the development of FISH, this technique has had a major impact on the capabilities of cytogenetics and pathology laboratories because ( I ) it is a rapid technique; (2) the efficiency of hybridization and detection is high; (3) the sensitivity and specificity is very high; (4) large numbers of cells can be analyzed in a short time; (5) cytogenetic data can be obtained from nondividing or terminally differentiated cells, or from poor samples that contain too few cells for routine cytogenetic studies, eg, samples obtained from patients shortly after chemotherapy or a bone marrow transplant; ( 6 ) the technique permits the direct correlation of cytogenetic and cytologic/morphologic features, which enables pathologists to differentiate malignant from benign conditions in equivocal cases; and (7) the technique may be adapted for automated systems.
HYBRIDIZATION TECHNIQUES
The technique of FISH is based on the same principle as Southern blot analysis, ie, the ability of single-stranded DNA to anneal to complementary DNA. As in Southern blot analysis, the target DNA is attached to a substrate; in the case of FISH, the target DNA is the nuclear DNA of interphase cells or the DNA of metaphase chromosomes that are affixed to a glass microscope slide (FISH can also be accomplished with bone marrow or peripheral blood smears, or fixed and sectioned tissue). The test probe is labeled, most commonly by enzymatic incorporation of biotin-or digoxigenin-labeled nucleotides. The cellular DNA and labeled probe DNA are denatured by heating in a formamide solution to form singlestranded DNA. A solution containing the probe DNA is a p plied to the microscope slide, the slides are covered with coverslips and sealed, and hybridization is allowed to occur by overnight incubation at 37°C to 40°C. Thereafter, the unbound probe is removed by extensive washes in formamide-SSC, and the slides are processed for probe detection.','
Biotin-labeled probes are usually detected with fluorescein isothiocyanate (FITC)-or rhodamine-conjugated avidin, whereas digoxigenin-labeled probes can be detected with HTC-labeled or rhodamine-labeled anti-digoxigenin antibodies. The slides are typically counterstained with DNAbinding fluorochromes, such as propidium iodide or 4,6-diamidino-2-phenylindole (DAPI). DAPI staining induces a chromosomal banding pattern that is identical to G-banding; thus, DAPI is preferred for the analysis of metaphase cells.
PROBES FOR FISH
Several types of probes can be used to detect chromosomal abnormalities by FISH. In general, these probes can be divided into three groups: those probes that identify a specific chromosome structure, those probes that hybridize to unique sequences, and those probes that hybridize to multiple chromosomal sequences. Examples of probes that hybridize to a specific chromosome structure include satellite DNA se-quences representing tandem DNA repeats that are present at the centromeres of human chromosomes. The satellite DNA that is present at the centromeres of most human chromosomes is unique, such that a probe derived from one chromosome will usually hybridize to that chromosome only. These probes are particularly suitable for the detection of numerical abn~rmalities.~-' At present, probes are available for all of the human chromosomes (GIBCO BRL, Gaithersburg, MD; and Oncor, Inc, Gaithersburg, MD).
FISH probes that contain a mixture of genomic sequences and hybridize to multiple chromosome sequences include chromosome-specific library probes. Library probes are typically prepared from flow-sorted chromosomes and, thus, they contain sequences derived from all parts ofthe chromosome. These probes paint the entire chromosome, and are especially useful in identifying structural rearrangements in metaphase cells, such as translocations.',2 They are not useful for the analysis of interphase cells, because the signal domains are very large and diffuse. At present, library probes are available commercially for chromosomes I-4,6-14, 16-18, and 22, and the X chromosome (GIBCO BRL and Oncor, Inc); probes for the remaining chromosomes are expected to be available soon. Genomic probes, such as cosmid and YAC clones, are also useful in detecting structural rearrangement^.',^
APPLICATIONS OF FISH
FISH techniques have a number ofapplications ( Table 1) . They have already altered the procedures used by many laboratories and promise to have a more substantial impact in the future. FISH is being used increasingly by pathology laboratories, providing a means of examining the karyotypic pattern of human tumors to the many institutions that do not have access to cytogenetic laboratory services. For cytogenetics laboratories, the application of FISH to the analysis of samples from leukemia patients may substantially decrease the number of cases that require a complete cytogenetic analysis. In some cases, FISH analysis provides more sensitivity, in that cytogenetic abnormalities have been identified by FISH in samples that appeared to be normal by morphologic and conventional cytogenetic ana lyse^.^.' FISH is most powerful when the analysis is targeted towards those abnormalities that are known to be associated with a particular tumor or disease. An example of how FISH could be used in a clinical setting is as follows. Cytogenetic analysis could be performed at the time of diagnosis to identify the chromosomal abnormalities in an individual patient's malignant cells. Thereafter, FISH could be used to detect residual disease or early relapse," and to assess the efficacy of therapeutic regimens.
Detection of numerical and structural chromosomal abnormalities. Hybridization of centromere-specific probes has been used to detect monosomy, trisomy, and other aneuploidies in both leukemias and solid tumor^.^-^.'^-^^ However, only one of the% studies examined the normal range of values for inteiphase analysis and established the sensitivity and specificity of FISH analysis6 Jenkins et a16 examined the clinical sensitivity (the percentage of abnormal cases classified as abnormal) and specificity (the percentage of normal cases analysis is a sensitive means of detecting trisomy 8. Moreover, this technique was useful in detecting trisomy 8 in specimens with normal or uncertain results by conventional cytogenetic analysis. In this study, the analysis of normal bone marrow samples showed that false monosomy and false trisomy is observed in approximately 2.23% and 0.71% of interphase cells, respectively. These results suggest that FISH analysis using centromere-specific probes will be useful for the detection of monosomy in pretreatment samples, but may have limited application in the detection of residual disease.
Chromosome-specific libraries, which paint the chromosomes, are particularly useful in identifying marker chromosomes (rearranged chromosomes of unidentified oriIn many cases, FISH has corrected the interpretation of chromosomal abnormalities that was based on cytogenetic analysis alone. Chromosomal translocations can be identified in interphase or metaphase cells by using probes (phage, cosmid, or yeast artificial chromosome probes) that are derived from the breakpoints of recurring translocations. For example, Tkachuk et als used probes for the ABL and BCR genes to detect the 1(9;22) in interphase cells from bone marrow specimens of patients who had chronic myelogenous leukemia (CML).
Whether FISH will be useful for the detection of chromosomal deletions in tumor cells has been a key issue. The data obtained from the analysis of leukemia cells with monosomy using centromere-specific probes suggested that it should be possible to detect deletions when present in a large proportion of the cells. However, the relatively high percentage of false monosomy (2% to 8% with centromere probes) may preclude the detection ofdeletions that are present in only a subpopulation of the tumor cells, or when tumor cells represent only a small percentage of the tissue sample.
In a pivotal study reported in this issue, Stilgenbauer et a l l 6 have demonstrated the use of FISH to detect allele loss in tumor cells, specifically the loss ofthe R B I gene in chronic lymphocytic leukemia (CLL). The investigators cohybridized phage clones spanning the entire RBI locus and a control probe derived from chromosome 2 1 using dual-color FISH. Peripheral blood cells of 35 patients (32 with CLL and 3 with B prolymphocytic leukemia) were analyzed. By cytogenetic analysis, 4 of 16 evaluable patients had monosomy 13 or deletions of 13q. FISH analysis detected the hemizygous loss of one RBI allele in each of these patients as well as in 7 other patients who were found to have normal karyotypes by cytogenetic studies (5 patients), who were found to have abnormalities not involving chromosome 13 (1 patient), or who were inevaluable by cytogenetic analysis (1 patient). Stilgenbauer et all6 established the range of signals using the RBI probe in normal cells (6% of cells had a single signal); evidence for a deletion of RBI was obtained if 2 12% of cells had a single signal (mean ? 3SD). Overall, 31% of patients had allelic loss of R B I , a frequency that is substantially higher than that observed by cytogenetic analysis (-13%). Of note is the fact that this frequency is equal to that observed in retinoblastomas. The frequency of cells with a single signal in patients with RBI deletions was 3 1% to 85%, suggesting that for CLL, RBI deletions, when present, occur in a sufficient proportion of leukemia cells to allow for sensitive detection by FISH.
This study is important for several reasons. First, the investigators have identified a genetic mutation in CLL, namely, loss of an RBI allele, and have established its frequency; this has ramifications both in understanding the biology and pathogenesis of the disease, as well as in the development of future diagnostic tests. Second, they have shown that FISH is a sensitive and accurate means of detecting gene loss or deletion. The ability to correctly identify RBI loss in CLL will be important in identifying the prognostic significance, if any, of this abnormality. It is not surprising that previous attempts to identify the prognostic significance of various recumng abnormalities in CLL, such as trisomy 12, were inconclusive when such a high proportion of patients with the abnormality were misclassified (described below).
With respect to deletions, FISH has also been used to define the commonly deleted segment, ie, the chromosomal segment that is deleted in all patients, in recurring deletions, such as the deletions of chromosome 5 that are observed in myeloid leukemias.'' By using FISH, several probes that fall within the critical region have been identified, these probes can now be used to detect the deletions in interphase cells from bone marrow samples from individuals at risk of developing acute myeloid leukemia (AML) or at the time of bone marrow dysfunction, as well as to iden@ a putative tumor suppressor gene within the commonly deleted segment.
Monitor the eflects of therapy and detect minimal residual disease. Posttreatment samples represent a substantial number of all cases analyzed by most clinical cancer cytogenetics laboratories. FISH provides a rapid means of targeting the analysis to detect residual leukemia cells. For example, samples from CML patients who are treated with a-interferon could be analyzed to determine the proportion of Philadelphia chromosome-positive cells. In patients with a myelodysplastic syndrome who are treated with growth factors, FISH can be used to determine the proportion of normal and abnormal cells in bone marrow and peripheral blood and to determine whether the growth factor induces maturation in normal cells, malignant cells, or both.
A recent study by Anastasi et all0 shows the usefulness of FISH in detecting early relapse. These investigators identified small numbers of cells that were suspicious for recurrent disease in bone marrow samples from two pediatric patients who were completing therapy for acute lymphoblastic leukemia (ALL). These cells could not be distinguished morphologically or immunophenotypically from hematogones (immature lymphoid cells). By conventional cytogenetic analysis, each patient had hyperdiploid ALL characterized by trisomy 17. Hybridization of a chromosome 17-specific probe to bone marrow aspirate smears permitted the direct correlation of cytogenetic findings with the suspicious cells on a cell-tocell basis. In one patient, the suspicious cells were found to have trisomy 17; the patient progressed subsequently to overt relapse. In contrast, FISH analysis of the suspicious cells in the second patient did not show the presence of trisomy 17, and this patient continues in remission more than 40 months after the completion of therapy.
Identification of the origin of bone marrow cells after bone marrow transplantation. The analysis of genetic markers is routinely used to evaluate the results of bone marrow transplantation. Although a number of methods have been used for the detection of host and recipient cells, eg, cytogenetic determination of the sex chromosome complement or restriction fragment polymorphism analysis, most methods suffer from a lack of sensitivity that makes the analysis of mixed cell populations difficult. Several groups of investigators have shown the applicability of FISH using X-and Y-chromosome-specific probes in detecting host cells, particularly in sex-mismatched transplants." These methods may be particularly useful for samples obtained shortly after transplantation, in which the cell number is very low (such samples are usually inadequate for conventional cytogenetic analysis).
An interesting issue in bone marrow transplantation is the rare examples of relapse of leukemia in donor cells. In one recent case, data from cytogenetic analysis suggested a relapse in donor cells; however, FISH analysis showed that the leukemia clone had recurred." These results suggest that the instances of relapse of leukemia in donor cells that were previously reported could have been incorrect if supported by cytogenetic data alone.
One of the advantages of FISH is that one can combine this method with morphologic or immunohistochemical assays to examine Detection of early relapse.
Identification of the lineage of neoplastic cells. 
RECENT ADVANCES IN FISH
A number of recent developments have led to improvements in FISH technology. These include the development of directly labeled probes as well as multicolor fluorescence techniques. In the first case, probes directly labeled with the fluorochrome are used for hybridization, thereby simplifying the technique by eliminating the probe detection steps. These probes have proven to yield strong signals, and appear to be suitable for clinical applications. 6 Multicolor fluorescence has been simplified with the development of dual-and triple-pass filters; thus, most laboratories now have the capacity to hybridize and detect two to three probes simultaneously.21 A new technique that may have broad applications in the analysis of human tumors is comparative genomic hybridization.22 Using this technique, DNA extracted from the tumor cells of interest is cohybridized with DNA from normal cells using dual-color FISH analysis of normal metaphase cells. Regions of gain or loss of DNA sequences, such as deletions, duplications, or amplifications, are seen as changes in the ratio of intensity of the two fluorochromes along target chromosomes. Thus, this technique allows the investigator to identify multiple genetic changes in the entire genome in a single step.
The availability of probes that are suitable for FISH is one of the major limitations of this diagnostic and experimental technique. Recently, new techniques for the construction of libraries from microdissected chromosomal bands have been developed; these techniques represent an elegant means of obtaining DNA probes from regions of particular interest and will be applicable to the detection of structural rearrangement~.*~ In addition, new methods for the labeling of yeast artificial chromosome and cosmid probes based on PCR amplification using random primers has resulted in improved labeling efficiency and stronger signals after FISH. During the past 5 years, FISH has had a major impact on many areas of laboratory medicine and biomedical research. Scientists, have indeed "gone fishing" in a well-stocked pond.
